Tesamorelin Reconstitution and Dosing: What Labeled Use and Papers Report
Educational review of tesamorelin reconstitution versus branded daily product, the 2 mg HIV-lipodystrophy label context, and how research vials differ from Egrifta-style instructions for use.
PeptIQ Team
Peptide Research & Education
PeptIQ app
Run Tesamorelin reconstitution math on the web
Use the calculator on this page or peptiq.io, then save the vial in PeptIQ to track doses, supply, reminders, and units-to-draw from your label.
# Tesamorelin Reconstitution and Dosing: What Labeled Use and Papers Report
> Note: PeptIQ is not a medical provider. This article is educational only. Labeled product instructions and published figures are not advice to obtain or use a research vial.
Tesamorelin is a stabilized analog of growth hormone-releasing hormone. The FDA approved a branded product (Egrifta) for reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. Spooner and Olin reviewed that indication and the daily clinical frame (PubMed 22298602). A StatPearls-style tesamorelin monograph also sits in the corpus (PubMed 31644039). ClinicalTrials.gov indexes the lipodystrophy program (search).
That labeled history is why tesamorelin dose conversations look more "official" than BPC-157 threads. The official number still belongs to a specific formulation, diluent, and indication.
Evidence tier
Layer
What it supports
What it does not
FDA-labeled product
2 mg subcutaneous daily in the approved HIV-lipodystrophy setting, per that product's instructions
A research-vial protocol for other goals
Phase III VAT trials
Visceral adipose and IGF-1 changes under study supply
Identity of an unlabeled powder
Community wellness logs
Off-label curiosity and tracking habits
Medical endorsement
First split: branded kit versus lyophilized listing
What someone is holding
What reconstitution usually means
Branded tesamorelin kit
Follow the exact instructions for use. Diluent, volume, and beyond-use dating are product-specific.
Compounded pharmacy syringe or vial
Ask the pharmacy for concentration and dating. Do not import a forum chart.
Gray-market lyophilized "tesamorelin"
Identity, fill weight, and salt form may be wrong. Math assumes a true label.
If the product is already in a dual-chamber device or pharmacy-prepared syringe, there is nothing to "reconstitute" from a 2 mL BAC-water habit.
Educational math for lyophilized listings only
When people apply generic peptide arithmetic to a claimed tesamorelin vial, they use:
Concentration (mg/mL) = labeled mg ÷ diluent mL
Volume (mL) = desired mg ÷ concentration
Illustrative example only
A vial labeled 2 mg with 1 mL bacteriostatic water is 2 mg/mL, so a 2 mg discussion figure is 1.0 mL. The same 2 mg with 2 mL of water is 1 mg/mL, so 2 mg is 2.0 mL, which is an awkward single insulin-syringe draw. Those examples show why branded kits exist. They are not a mixing protocol.
Tesamorelin is often described as more fragile than simpler repair peptides. Community education warns against same-syringe mixes with copper peptides or GLP-1 solutions. That is a chemistry caution.
Research-reference range
The figure that dominates both papers and clinic talk is 2 mg once daily subcutaneously in the approved HIV-associated lipodystrophy program. Trial supply used that daily frame. Wellness-community posts sometimes copy 2 mg daily for other body-composition goals. Copying a labeled milligram onto a different indication and an unlabeled vial is a leap the papers do not make.
PeptIQ users who log tesamorelin often record daily entries and pair IGF-1 or waist-adjacent notes when they track labs. Those are observational fields. They are not proof of benefit outside the studied indication.
Related reading on this site covers tesamorelin science, visceral-fat meta-analysis, and waist-first tracking. This page stays on reconstitution context and evidence tiers.
Route language
Labeled tesamorelin is a subcutaneous daily product. Injection-site rotation and device steps belong in the instructions for use, not in a blog walkthrough.
Bottom line
Tesamorelin has a real labeled daily milligram in a narrow indication. Reconstitution for a branded kit is the IFU. Reconstitution for an unlabeled vial is generic math plus high identity risk. Educational use only.